Eruptive sebaceous hyperplasia as a side effect of oral tacrolimus in a renal transplant recipient

14Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Sebaceous hyperplasia, a benign proliferation of sebaceous glands, has been well documented in organ transplant recipients treated with cyclosporine. Sebaceous hyperplasia has not been strongly associated with any other immunosuppressive medications. We report a case of eruptive sebaceous hyperplasia in a renal transplant recipient with no previous exposure to cyclosporine that was recently started on tacrolimus, mycophenolate mofetil, and prednisone. To our knowledge, this is the first report of eruptive sebaceous hyperplasia in a renal transplant recipient who was immunosuppressed with tacrolimus and had no prior exposure to cyclosporine.

Cite

CITATION STYLE

APA

Levandoski, K. A., Girardi, N. A., & Loss, M. J. (2017). Eruptive sebaceous hyperplasia as a side effect of oral tacrolimus in a renal transplant recipient. Dermatology Online Journal. Dermatology Online Journal. https://doi.org/10.5070/d3235034932

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free